Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
1.740
-0.140 (-7.45%)
At close: Nov 4, 2024, 4:00 PM
1.810
+0.070 (4.02%)
Pre-market: Nov 5, 2024, 6:49 AM EST
Sangamo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 362 | 96 | 515 | 1,093 | 2,207 | 970 | |
| Market Cap Growth | -66.71% | -81.28% | -52.90% | -50.50% | 127.45% | -17.20% | |
| Enterprise Value | 364 | -1 | 204 | 614 | 1,554 | 607 | |
| Last Close Price | 1.74 | 0.54 | 3.14 | 7.50 | 15.61 | 8.37 | |
| PE Ratio | - | -0.37 | -2.51 | -6.08 | -17.34 | -9.86 | |
| PS Ratio | 26.33 | 0.55 | 4.62 | 9.87 | 18.67 | 9.47 | |
| PB Ratio | 15.29 | 1.16 | 1.74 | 2.91 | 4.44 | 2.24 | |
| P/FCF Ratio | -0.42 | -0.39 | -2.11 | -4.26 | 14.23 | -5.88 | |
| P/OCF Ratio | -0.43 | -0.43 | -2.30 | -4.68 | 12.99 | -6.72 | |
| EV/Sales Ratio | 29.62 | 0.00 | 1.83 | 5.54 | 13.15 | 5.92 | |
| EV/EBITDA Ratio | -0.27 | 0.01 | -1.08 | -3.53 | -12.54 | -5.99 | |
| EV/EBIT Ratio | -0.26 | 0.01 | -1.01 | -3.35 | -11.99 | -5.77 | |
| EV/FCF Ratio | -0.28 | 0.00 | -0.84 | -2.39 | 10.01 | -3.67 | |
| Debt / Equity Ratio | 1.23 | 0.46 | 0.15 | 0.13 | 0.08 | 0.10 | |
| Debt / FCF Ratio | -0.16 | -0.15 | -0.18 | -0.19 | 0.27 | -0.27 | |
| Asset Turnover | 0.06 | 0.48 | 0.17 | 0.13 | 0.15 | 0.17 | |
| Quick Ratio | 0.73 | 1.72 | 2.53 | 2.99 | 4.51 | 5.73 | |
| Current Ratio | 1.03 | 1.98 | 2.69 | 3.12 | 4.60 | 5.80 | |
| Return on Equity (ROE) | -194.05% | -136.47% | -57.37% | -40.86% | -26.04% | -23.85% | |
| Return on Assets (ROA) | -58.29% | -17.60% | -19.59% | -13.80% | -10.27% | -10.71% | |
| Return on Capital (ROIC) | -75.50% | -27.91% | -33.04% | -23.80% | -15.93% | -15.57% | |
| Earnings Yield | -68.91% | -267.59% | -37.37% | -16.32% | -5.48% | -9.81% | |
| FCF Yield | -49.35% | -255.31% | -47.38% | -23.48% | 7.03% | -17.01% | |
| Buyback Yield / Dilution | -11.58% | -13.02% | -6.76% | -7.53% | -19.92% | -15.65% | |
| Total Shareholder Return | -11.58% | -13.02% | -6.76% | -7.53% | -19.92% | -15.65% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.